1. Home
  2. AUB vs VRNA Comparison

AUB vs VRNA Comparison

Compare AUB & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUB
  • VRNA
  • Stock Information
  • Founded
  • AUB 1902
  • VRNA 2005
  • Country
  • AUB United States
  • VRNA United Kingdom
  • Employees
  • AUB N/A
  • VRNA N/A
  • Industry
  • AUB Major Banks
  • VRNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AUB Finance
  • VRNA Health Care
  • Exchange
  • AUB Nasdaq
  • VRNA Nasdaq
  • Market Cap
  • AUB 3.3B
  • VRNA 2.9B
  • IPO Year
  • AUB N/A
  • VRNA 2017
  • Fundamental
  • Price
  • AUB $41.90
  • VRNA $37.86
  • Analyst Decision
  • AUB Buy
  • VRNA Strong Buy
  • Analyst Count
  • AUB 4
  • VRNA 6
  • Target Price
  • AUB $39.25
  • VRNA $43.83
  • AVG Volume (30 Days)
  • AUB 1.1M
  • VRNA 1.1M
  • Earning Date
  • AUB 10-21-2024
  • VRNA 11-04-2024
  • Dividend Yield
  • AUB 3.23%
  • VRNA N/A
  • EPS Growth
  • AUB N/A
  • VRNA N/A
  • EPS
  • AUB 2.38
  • VRNA N/A
  • Revenue
  • AUB $741,145,000.00
  • VRNA $5,624,000.00
  • Revenue This Year
  • AUB N/A
  • VRNA N/A
  • Revenue Next Year
  • AUB $38.57
  • VRNA $554.09
  • P/E Ratio
  • AUB $17.32
  • VRNA N/A
  • Revenue Growth
  • AUB 9.38
  • VRNA 1127.95
  • 52 Week Low
  • AUB $30.22
  • VRNA $11.39
  • 52 Week High
  • AUB $43.57
  • VRNA $40.13
  • Technical
  • Relative Strength Index (RSI)
  • AUB 59.37
  • VRNA 57.91
  • Support Level
  • AUB $40.96
  • VRNA $34.51
  • Resistance Level
  • AUB $43.11
  • VRNA $40.13
  • Average True Range (ATR)
  • AUB 1.07
  • VRNA 2.27
  • MACD
  • AUB 0.00
  • VRNA -0.16
  • Stochastic Oscillator
  • AUB 75.72
  • VRNA 73.40

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other.

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Share on Social Networks: